Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pliant Therapeutics, Inc. (PLRX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pliant Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1746473.
Total stock buying since 2020: $0.
Total stock sales since 2020: $25,795,571.
Total stock option exercises since 2020: $1,893,954.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 134,221 | $1,501,279 | 0 | $0 |
| 2024 | 0 | $0 | 140,276 | $1,966,208 | 21,000 | $43,680 |
| 2023 | 0 | $0 | 673,462 | $18,001,680 | 357,141 | $1,342,503 |
| 2022 | 0 | $0 | 106,635 | $2,163,600 | 31,498 | $65,515 |
| 2021 | 0 | $0 | 34,000 | $1,180,282 | 50,500 | $105,040 |
| 2020 | 0 | $0 | 34,734 | $982,522 | 94,874 | $337,216 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-01 | 0 | $0 | 134,221 | $1,501,279 | 0 | $0 |
| 2024-07 | 0 | $0 | 79,496 | $918,972 | 0 | $0 |
| 2024-05 | 0 | $0 | 0 | $0 | 21,000 | $43,680 |
| 2024-01 | 0 | $0 | 60,780 | $1,047,236 | 0 | $0 |
| 2023-08 | 0 | $0 | 34,919 | $698,580 | 10,591 | $22,029 |
| 2023-07 | 0 | $0 | 147,712 | $2,657,960 | 0 | $0 |
| 2023-06 | 0 | $0 | 0 | $0 | 36,550 | $76,024 |
| 2023-04 | 0 | $0 | 2,877 | $77,955 | 0 | $0 |
| 2023-03 | 0 | $0 | 70,454 | $1,868,508 | 0 | $0 |
| 2023-02 | 0 | $0 | 45,000 | $1,546,320 | 45,000 | $279,900 |
| 2023-01 | 0 | $0 | 372,500 | $11,152,357 | 265,000 | $964,550 |
| 2022-12 | 0 | $0 | 71,137 | $1,359,656 | 4,000 | $8,320 |
| 2022-10 | 0 | $0 | 5,000 | $125,239 | 0 | $0 |
| 2022-07 | 0 | $0 | 30,498 | $678,705 | 27,498 | $57,195 |
| 2021-09 | 0 | $0 | 0 | $0 | 20,000 | $41,600 |
| 2021-06 | 0 | $0 | 4,000 | $133,344 | 0 | $0 |
| 2021-05 | 0 | $0 | 3,500 | $101,157 | 4,500 | $9,360 |
| 2021-04 | 0 | $0 | 3,500 | $106,162 | 6,000 | $12,480 |
| 2021-03 | 0 | $0 | 16,000 | $630,610 | 20,000 | $41,600 |
| 2021-02 | 0 | $0 | 3,500 | $115,542 | 0 | $0 |
| 2021-01 | 0 | $0 | 3,500 | $93,467 | 0 | $0 |
| 2020-12 | 0 | $0 | 34,734 | $982,522 | 26,734 | $94,386 |
| 2020-04 | 0 | $0 | 0 | $0 | 68,140 | $242,830 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-22 | Ouimette Mike (General Counsel & Corp. Sec'y) | Sale | 10,230 | 10.99 | 112,458 |
| 2025-01-17 | Cheung Lily (Chief Human Resource Officer) | Sale | 3,740 | 11.20 | 41,891 |
| 2025-01-17 | Ouimette Mike (General Counsel & Corp. Sec'y) | Sale | 13,270 | 11.20 | 148,637 |
| 2025-01-17 | Cummings Keith Lamont (Chief Financial Officer) | Sale | 20,148 | 11.20 | 225,677 |
| 2025-01-17 | Coulie Bernard (President and CEO) | Sale | 52,419 | 11.20 | 587,145 |
| 2025-01-17 | Hull Hans (Chief Business Officer) | Sale | 15,936 | 11.20 | 178,499 |
| 2025-01-17 | Lefebvre Eric (Chief Medical Officer) | Sale | 18,478 | 11.20 | 206,972 |
| 2024-07-10 | Ouimette Mike (General Counsel & Corp. Sec'y) | Sale | 7,656 | 11.56 | 88,503 |
| 2024-07-10 | Cummings Keith Lamont (Chief Financial Officer) | Sale | 10,911 | 11.56 | 126,131 |
| 2024-07-10 | Coulie Bernard (President and CEO) | Sale | 38,710 | 11.56 | 447,487 |
| 2024-07-10 | Hull Hans (Chief Business Officer) | Sale | 9,900 | 11.56 | 114,444 |
| 2024-07-10 | Lefebvre Eric (Chief Medical Officer) | Sale | 12,319 | 11.56 | 142,407 |
| 2024-05-02 | Cummings Keith Lamont (Chief Financial Officer) | Option Ex | 21,000 | 2.08 | 43,680 |
| 2024-01-17 | Ouimette Mike (General Counsel & Corp. Sec'y) | Sale | 5,197 | 17.23 | 89,544 |
| 2024-01-17 | Cummings Keith Lamont (Chief Financial Officer) | Sale | 9,781 | 17.23 | 168,526 |
| 2024-01-17 | Coulie Bernard (President and CEO) | Sale | 25,721 | 17.23 | 443,172 |
| 2024-01-17 | Hull Hans (Chief Business Officer) | Sale | 9,786 | 17.23 | 168,612 |
| 2024-01-17 | Lefebvre Eric (Chief Medical Officer) | Sale | 10,295 | 17.23 | 177,382 |
| 2023-08-04 | Hull Hans (Chief Business Officer) | Sale | 20,050 | 20.01 | 401,200 |
| 2023-08-04 | Hull Hans (Chief Business Officer) | Option Ex | 8,791 | 2.08 | 18,285 |
| 2023-08-03 | Hull Hans (Chief Business Officer) | Sale | 14,869 | 20.00 | 297,380 |
| 2023-08-03 | Hull Hans (Chief Business Officer) | Option Ex | 1,800 | 2.08 | 3,744 |
| 2023-07-20 | Ouimette Mike (General Counsel & Corp. Sec'y) | Sale | 4,755 | 17.55 | 83,450 |
| 2023-07-17 | Ouimette Mike (General Counsel & Corp. Sec'y) | Sale | 12,778 | 18.01 | 230,119 |
| 2023-07-17 | Cummings Keith Lamont (Chief Financial Officer) | Sale | 19,771 | 18.01 | 356,055 |
| 2023-07-17 | Coulie Bernard (President and CEO) | Sale | 70,150 | 18.01 | 1,263,331 |
| 2023-07-17 | Hull Hans (Chief Business Officer) | Sale | 17,937 | 18.01 | 323,027 |
| 2023-07-17 | Lefebvre Eric (Chief Medical Officer) | Sale | 22,321 | 18.01 | 401,978 |
| 2023-06-13 | Cummings Keith Lamont (Chief Financial Officer) | Option Ex | 30,750 | 2.08 | 63,960 |
| 2023-06-09 | Cummings Keith Lamont (Chief Financial Officer) | Option Ex | 5,800 | 2.08 | 12,064 |
| 2023-04-03 | Ouimette Mike (General Counsel & Corp. Sec'y) | Sale | 2,877 | 27.10 | 77,955 |
| 2023-03-30 | Ouimette Mike (General Counsel & Corp. Sec'y) | Sale | 4,874 | 26.52 | 129,263 |
| 2023-03-30 | Cummings Keith Lamont (Chief Financial Officer) | Sale | 9,960 | 26.52 | 264,149 |
| 2023-03-30 | Coulie Bernard (President and CEO) | Sale | 35,339 | 26.52 | 937,225 |
| 2023-03-30 | Hull Hans (Chief Business Officer) | Sale | 9,036 | 26.52 | 239,643 |
| 2023-03-30 | Lefebvre Eric (Chief Medical Officer) | Sale | 11,245 | 26.52 | 298,228 |
| 2023-02-03 | Coulie Bernard (President and CEO) | Sale | 15,000 | 33.72 | 505,800 |
| 2023-02-03 | Coulie Bernard (President and CEO) | Option Ex | 15,000 | 6.22 | 93,300 |
| 2023-02-02 | Coulie Bernard (President and CEO) | Sale | 15,000 | 34.54 | 518,130 |
| 2023-02-02 | Coulie Bernard (President and CEO) | Option Ex | 15,000 | 6.22 | 93,300 |
| 2023-02-01 | Coulie Bernard (President and CEO) | Sale | 15,000 | 34.83 | 522,390 |
| 2023-02-01 | Coulie Bernard (President and CEO) | Option Ex | 15,000 | 6.22 | 93,300 |
| 2023-01-31 | Coulie Bernard (President and CEO) | Sale | 15,000 | 34.92 | 523,755 |
| 2023-01-31 | Coulie Bernard (President and CEO) | Option Ex | 15,000 | 4.15 | 62,250 |
| 2023-01-30 | Coulie Bernard (President and CEO) | Sale | 15,000 | 34.32 | 514,755 |
| 2023-01-30 | Coulie Bernard (President and CEO) | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-27 | Coulie Bernard (President and CEO) | Sale | 25,000 | 35.80 | 895,025 |
| 2023-01-27 | Coulie Bernard (President and CEO) | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-26 | Coulie Bernard (President and CEO) | Sale | 30,000 | 35.19 | 1,055,790 |
| 2023-01-26 | Coulie Bernard (President and CEO) | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-25 | Coulie Bernard (President and CEO) | Sale | 15,000 | 32.84 | 492,675 |
| 2023-01-25 | Coulie Bernard (President and CEO) | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-24 | Coulie Bernard (President and CEO) | Sale | 15,000 | 30.89 | 463,395 |
| 2023-01-24 | Coulie Bernard (President and CEO) | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-23 | Ouimette Mike (General Counsel & Corp. Sec'y) | Sale | 20,000 | 34.19 | 683,880 |
| 2023-01-23 | Ouimette Mike (General Counsel & Corp. Sec'y) | Option Ex | 20,000 | 18.09 | 361,800 |
| 2023-01-23 | Cummings Keith Lamont (Chief Financial Officer) | Sale | 30,000 | 35.00 | 1,050,000 |
| 2023-01-23 | Cummings Keith Lamont (Chief Financial Officer) | Option Ex | 30,000 | 4.15 | 124,500 |
| 2023-01-23 | Coulie Bernard (President and CEO) | Sale | 30,000 | 34.55 | 1,036,380 |
| 2023-01-23 | Coulie Bernard (President and CEO) | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-23 | Lefebvre Eric (Chief Medical Officer) | Sale | 67,500 | 34.48 | 2,327,602 |
| 2023-01-09 | Coulie Bernard (President and CEO) | Sale | 5,000 | 19.17 | 95,830 |
| 2023-01-09 | Coulie Bernard (President and CEO) | Option Ex | 5,000 | 2.08 | 10,400 |
| 2023-01-06 | Coulie Bernard (President and CEO) | Sale | 15,000 | 19.04 | 285,585 |
| 2023-01-06 | Coulie Bernard (President and CEO) | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-04 | Coulie Bernard (President and CEO) | Sale | 30,000 | 19.06 | 571,890 |
| 2023-01-04 | Coulie Bernard (President and CEO) | Option Ex | 30,000 | 2.08 | 62,400 |
| 2023-01-03 | Coulie Bernard (President and CEO) | Sale | 30,000 | 19.33 | 579,900 |
| 2023-01-03 | Coulie Bernard (President and CEO) | Option Ex | 30,000 | 2.08 | 62,400 |
| 2022-12-22 | Ouimette Mike (General Counsel & Corp. Sec'y) | Sale | 2,928 | 19.38 | 56,730 |
| 2022-12-22 | Cummings Keith Lamont (Chief Financial Officer) | Option Ex | 4,000 | 2.08 | 8,320 |
| 2022-12-20 | Ouimette Mike (General Counsel & Corp. Sec'y) | Sale | 4,719 | 19.10 | 90,142 |
| 2022-12-20 | Cummings Keith Lamont (Chief Financial Officer) | Sale | 9,643 | 19.10 | 184,200 |
| 2022-12-20 | Coulie Bernard (President and CEO) | Sale | 34,212 | 19.10 | 653,517 |
| 2022-12-20 | Hull Hans (Chief Business Officer) | Sale | 8,748 | 19.10 | 167,104 |
| 2022-12-20 | Lefebvre Eric (Chief Medical Officer) | Sale | 10,887 | 19.10 | 207,963 |
| 2022-10-25 | Lefebvre Eric (Chief Medical Officer) | Sale | 5,000 | 25.05 | 125,239 |
| 2022-07-12 | Coulie Bernard (President and CEO) | Sale | 12,498 | 22.50 | 281,205 |
| 2022-07-12 | Coulie Bernard (President and CEO) | Option Ex | 12,498 | 2.08 | 25,995 |
| 2022-07-11 | Coulie Bernard (President and CEO) | Sale | 15,000 | 22.50 | 337,500 |
| 2022-07-11 | Coulie Bernard (President and CEO) | Option Ex | 15,000 | 2.08 | 31,200 |
| 2022-07-11 | Lefebvre Eric (Chief Medical Officer) | Sale | 3,000 | 20.00 | 60,000 |
| 2021-09-03 | Cummings Keith Lamont (Chief Financial Officer) | Option Ex | 20,000 | 2.08 | 41,600 |
| 2021-06-14 | Coulie Bernard (President and CEO) | Sale | 4,000 | 33.34 | 133,344 |
| 2021-05-26 | Hull Hans (Chief Business Officer) | Option Ex | 4,500 | 2.08 | 9,360 |
| 2021-05-14 | Coulie Bernard (President and CEO) | Sale | 3,500 | 28.90 | 101,157 |
| 2021-04-14 | Coulie Bernard (President and CEO) | Sale | 3,500 | 30.33 | 106,162 |
| 2021-04-13 | Coulie Bernard (President and CEO) | Option Ex | 6,000 | 2.08 | 12,480 |
| 2021-03-18 | Lefebvre Eric (Chief Medical Officer) | Sale | 12,500 | 39.58 | 494,737 |
| 2021-03-15 | Coulie Bernard (President and CEO) | Sale | 3,500 | 38.82 | 135,873 |
| 2021-03-05 | Cummings Keith Lamont (Chief Financial Officer) | Option Ex | 20,000 | 2.08 | 41,600 |
| 2021-02-16 | Coulie Bernard (President and CEO) | Sale | 3,500 | 33.01 | 115,542 |
| 2021-01-14 | Coulie Bernard (President and CEO) | Sale | 3,500 | 26.70 | 93,467 |
| 2020-12-30 | Hull Hans (Chief Business Officer) | Option Ex | 3,500 | 2.08 | 7,280 |
| 2020-12-21 | Cummings Keith Lamont (Chief Financial Officer) | Option Ex | 4,500 | 2.08 | 9,360 |
| 2020-12-18 | Lefebvre Eric (Chief Medical Officer) | Sale | 12,500 | 26.57 | 332,187 |
| 2020-12-14 | Coulie Bernard (President and CEO) | Sale | 3,500 | 27.59 | 96,558 |
| 2020-12-01 | Cummings Keith Lamont (Chief Financial Officer) | Sale | 18,734 | 29.56 | 553,777 |
| 2020-12-01 | Cummings Keith Lamont (Chief Financial Officer) | Option Ex | 18,734 | 4.15 | 77,746 |
| 2020-04-30 | Cummings Keith Lamont (Chief Financial Officer) | Option Ex | 19,300 | 2.08 | 40,144 |
| 2020-04-30 | Coulie Bernard (President and CEO) | Option Ex | 48,840 | 4.15 | 202,686 |
Insider trading activities including stock purchases, stock sales, and option exercises of PLRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pliant Therapeutics, Inc. (symbol PLRX, CIK number 1746473) see the Securities and Exchange Commission (SEC) website.